
|Articles|March 21, 2018
PAREXEL Introduces Integrated Medical Writing Solutions Service Offering
Advertisement
PAREXEL International Corporation introduced PAREXEL's Medical Writing Solutions, a new offering that provides several communication services needed throughout each critical stage of the drug development and commercialization process.
The medical writing solutions team is made up of hundreds of trained experts that develop high quality documents which are compliant with the latest regulations and guidelines in order to drive value for clients.
The offering is currently available as both functional service projects or as part of larger strategic partnerships based on their study needs. For more information visit
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




